JPRN-UMIN000019135Completed未知
GENeral practitioners and Embolism pRevention in NVAF patients treated with RivAroxaban : reaL life evidence - GENeRA
Japan Cardiovascular Research Foundation0 sites5,732 target enrollmentStarted: September 28, 2015Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Enrollment
- 5,732
Study Overview
Brief Summary
Currently being analyzed
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 20years-old to ot applicable (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •- Patients are contraindicated for rivaroxaban - Patients judged as inappropriate for this study by investigators
Investigators
Similar Trials
Recruiting
Not Applicable
Safety and Efficacy of Prophylactic Arterial Embolization in the Treatment of Angiography-negative Acute Upper Gastrointestinal BleedingAcute Gastrointestinal BleedingNCT05550649Shanghai 10th People's Hospital60
Completed
Not Applicable
Evaluation of the Amiens University Hospital Neuroradiology Anticoagulation ProtocolAneurysmNCT02848612Centre Hospitalier Universitaire, Amiens459
Completed
Phase 4
Randomized control study comparing various modalities of thromboprophylaxis used after total knee and hip arthroplastyCTRI/2016/03/006736All India Institute of Medical Sciences300
Completed
Not Applicable
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill PatientsHemorrhageVenous ThromboembolismNCT02213978Beijing Chao Yang Hospital1,114
Terminated
Not Applicable
Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic SystemPeripheral Vascular DiseaseNCT02369692Hansen Medical15